Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2005300150 (hide)

Owner AstraZeneca AB

Inventors Lepisto, Matti; Henriksson, Krister; Hulikal, Vijaykumar; Bladh, Hakan

Agent Freehills

Pub. Number AU-A-2005300150

PCT Pub. Number WO2006/046916

Priority 0500651-5 22.03.05 SE; 0402636-5 29.10.04 SE

Filing date 26 October 2005

Wipo publication date 4 May 2006

International Classifications

C07C 311/16 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/47 (2006.01) - Quinolines

A61K 31/63 (2006.01) - Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide

A61K 31/635 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 311/17 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/18 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/29 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/40 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 209/14 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/42 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/44 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 239/69 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/80 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

26 April 2007 PCT application entered the National Phase

  PCT publication WO2006/046916 Priority application(s): WO2006/046916

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300164-Exhaust for automobile

2005300148-Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases